Skip to content

DS-COG-AML (v1.0)

No due date 0% complete

Study Title:

  • Mechanisms, Genomic Risk Stratification and Precision Intervention for Acute Myeloid Leukemia in Children with Down syndrome (ML-DS)

Principal Investigators:

  • Meshinchi, Soheil, PhD

Description:

  • We will apply sophisticated sequencing technology to a large cohort of samples from children with myeloid leukemia, relapsed leukemia and transie…

Study Title:

  • Mechanisms, Genomic Risk Stratification and Precision Intervention for Acute Myeloid Leukemia in Children with Down syndrome (ML-DS)

Principal Investigators:

  • Meshinchi, Soheil, PhD

Description:

  • We will apply sophisticated sequencing technology to a large cohort of samples from children with myeloid leukemia, relapsed leukemia and transient leukemia of DS. We will scan all leukemic cell genes for damage (whole genome sequencing), abnormal activity (RNA-Seq) and presence of marks that change activity but not information content of genes (epigenetic or methylation analysis).

Scope:
The data types included in the MVP release includes the following:

  • Participants
  • Conditions

Data types out of scope for the MVP release includes:

  • RNASeq
  • Methylation
Loading